A Novel ATP1A2 Gene Variant Associated With Pure Sporadic Hemiplegic Migraine Improved After Patent Foramen Ovale Closure: A Case Report.

MLA

Perrotta, Armando, et al. “A Novel ATP1A2 Gene Variant Associated With Pure Sporadic Hemiplegic Migraine Improved After Patent Foramen Ovale Closure: A Case Report.” Frontiers in Neurology, May 2018, pp. 1–4. EBSCOhost, https://doi.org/10.3389/fneur.2018.00332.

APA

Perrotta, A., Gambardella, S., Ambrosini, A., Anastasio, M. G., Albano, V., Fornai, F., & Pierelli, F. (2018). A Novel ATP1A2 Gene Variant Associated With Pure Sporadic Hemiplegic Migraine Improved After Patent Foramen Ovale Closure: A Case Report. Frontiers in Neurology, 1–4. https://doi.org/10.3389/fneur.2018.00332

Chicago

Perrotta, Armando, Stefano Gambardella, Anna Ambrosini, Maria Grazia Anastasio, Veronica Albano, Francesco Fornai, and Francesco Pierelli. 2018. “A Novel ATP1A2 Gene Variant Associated With Pure Sporadic Hemiplegic Migraine Improved After Patent Foramen Ovale Closure: A Case Report.” Frontiers in Neurology, May, 1–4. doi:10.3389/fneur.2018.00332.